US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 1, 2013 (13 years ago)

Nifedipine

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.

What was recalled

Nifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENSTONE LLC, Pespack, NJ,07977, NDC 59762-6692-8

Recalling firm
Greenstone Llc
NDC code
59762-6692-8
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-737-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all
Class II · Moderate risk Ongoing

Amlodipine and Olmesartan Medoxomil Tablets

Reason Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Ascend Laboratories, LLC D-0712-2026
Class II · Moderate risk Ongoing

Cleviprex

Reason Lack of Assurance of Sterility

Chiesi USA, Inc. NDC 10122-611-10 D-0689-2026
Class III · Low risk Ongoing

Epinephrine Injection

Reason Failed Impurities/Degradations Specifications

Fresenius Kabi USA, LLC NDC 63323-696-02 D-0581-2026
Class II · Moderate risk Ongoing

Amlodipine and Olmesartan Medoxomil Tablets

Reason Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Ascend Laboratories, LLC NDC 67877-501-30 D-0556-2026
Class II · Moderate risk Ongoing

EPINEPHRINE Injection

Reason Lack of Assurance of Sterility

International Medication Systems Ltd. NDC 76329-3318-1 D-0483-2026